Product Information
DILTIAZEM 12HR ER 60 MG CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.5119 per EA under NDC 68462085001. Its NADAC has been published 280 times since Apr 14, 2021.
FDA first approved this application on Mar 22, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462085001
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212317FDA Approved
3/22/2021
TE Code
AB1
On Market Since
3/22/2021
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 12HR ER 60 MG CAP has been published 280 times since Apr 14, 2021, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5119 per EA |
|---|---|
| All-time high | $2.6517 (Aug 16, 2023) |
| All-time low | $1.3539 (Oct 22, 2025) |
| 52-week high | $1.7362 |
| 52-week low | $1.3539 |
| Median price | $1.9968 |
| Average price | $1.9956 |
| Largest weekly change | +27.9% (Jan 18, 2023) |
| Weeks tracked | 280 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DILTIAZEM 12HR ER 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 60 MG CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.5119 per EA (NDC 68462085001), effective Aug 19, 2026.
How has the price of DILTIAZEM 12HR ER 60 MG CAP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 60 MG CAP has declined 34.1%. It has been tracked across 280 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 60 MG CAP?
Since Apr 14, 2021, the NADAC for DILTIAZEM 12HR ER 60 MG CAP has ranged from a low of $1.3539 (Oct 22, 2025) to a high of $2.6517 (Aug 16, 2023), with a median of $1.9968 per EA.
Are there cheaper alternatives to DILTIAZEM 12HR ER 60 MG CAP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 12HR ER 60 MG CAP, is $1.3744 per EA — about 9% below DILTIAZEM 12HR ER 60 MG CAP.
Who manufactures DILTIAZEM 12HR ER 60 MG CAP?
DILTIAZEM 12HR ER 60 MG CAP (NDC 68462085001) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.